Otsuka America Pharmaceutical, Inc. has developed an easy-to-use Hyponatremia Registry Study Results Interactive Tool to help you understand how the subjects in the Global Hyponatremia Registry Study (Registry) responded to fluid restriction. Response in the context of the Registry is defined by an increase in a study subject’s serum sodium by at least 2 or 3 or 4 mEq/L over a 24‐hour period.

Input a hypothetical patient’s characteristics and laboratory values, and choose from selected clinical considerations to see how similarly situated study subjects responded to fluid restriction.

This tool has not been evaluated by the U.S. Food and Drug Administration. It is not intended to diagnose, treat, cure, or prevent any medical condition, disease, or health problem. Users of the application should not rely on information provided by the application—including the data—to diagnose or treat any medical condition, disease, or health problem.

What’s New

Version 1.2.26

Bug Fixes

App Privacy

The developer, Otsuka America Pharmaceutical, Inc., has not provided details about its privacy practices and handling of data to Apple.

No Details Provided

The developer will be required to provide privacy details when they submit their next app update.


  • Family Sharing

    With Family Sharing set up, up to six family members can use this app.

More By This Developer

You May Also Like